JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.17% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
PUT
Carnival Corporation Ltd
CCL
$38.5B
| $3.04M | ﹤0.01% |
300,000
-181,800
| -38% | -$1.88M |
|
3077
Larimar Therapeutics
LRMR
$453M
| $3.04M | ﹤0.01% |
671,857
+627,067
| +1,400% | +$3.28M |
|
3078
Astrana Health
ASTH
$2.02B
| $3.04M | ﹤0.01% |
83,333
+11,940
| +17% | +$418K |
|
3079
PUT
Regions Financial
RF
$27.2B
| $3.04M | ﹤0.01% |
+163,600
| New | +$3.56M |
|
3080
Lucid Motors
LCID
$2.45B
| $3.03M | ﹤0.01% |
37,716
+5,372
| +17% | +$477K |
|
3081
Vicor
VICR
$10.8B
| $3.03M | ﹤0.01% |
64,614
+8,523
| +15% | +$473K |
|
|
CIM
3082
Chimera Investment
CIM
$988M
| $3.03M | ﹤0.01% |
179,158
+38,936
| +28% | +$745K |
|
3083
Lightspeed Commerce
LSPD
$1.38B
| $3.03M | ﹤0.01% |
199,733
+31,422
| +19% | +$498K |
|
|
TWO
3084
Two Harbors Investment
TWO
$1.27B
| $3.03M | ﹤0.01% |
206,080
+116,435
| +130% | +$1.89M |
|
3085
Invesco S&P 500 Revenue ETF
RWL
$10B
| $3.03M | ﹤0.01% |
39,830
+11,416
| +40% | +$868K |
|
|
FBMS
3086
DELISTED
The First Bancshares, Inc.
FBMS
| $3.03M | ﹤0.01% |
117,315
+5,331
| +5% | +$157K |
|
3087
Levi Strauss
LEVI
$8.68B
| $3.03M | ﹤0.01% |
166,177
+95,878
| +136% | +$1.65M |
|
3088
RLX Technology
RLX
$2.37B
| $3.03M | ﹤0.01% |
1,043,651
-532,138
| -34% | -$1.29M |
|
3089
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.1B
| $3.02M | ﹤0.01% |
59,972
-53,322
| -47% | -$2.63M |
|
|
SNBR
3090
DELISTED
Sleep Number
SNBR
| $3.02M | ﹤0.01% |
99,208
-30,252
| -23% | -$988K |
|
3091
Invesco S&P 500 Pure Value ETF
RPV
$1.75B
| $3.01M | ﹤0.01% |
39,701
+11,805
| +42% | +$958K |
|
|
BLU
3092
DELISTED
BELLUS Health Inc.
BLU
| $3.01M | ﹤0.01% |
418,416
+59,854
| +17% | +$464K |
|
3093
Univest Financial
UVSP
$1.19B
| $3.01M | ﹤0.01% |
126,699
+91,564
| +261% | +$2.42M |
|
3094
John B. Sanfilippo & Son
JBSS
$1.01B
| $3M | ﹤0.01% |
31,016
+8,086
| +35% | +$722K |
|
3095
AllianzIM U.S. Equity Buffer20 Oct ETF
OCTW
$323M
| $3M | ﹤0.01% |
103,071
+398
| +0.4% | +$11.4K |
|
3096
iShares Core 10+ Year USD Bond ETF
ILTB
$592M
| $2.99M | ﹤0.01% |
55,707
+1,840
| +3% | +$97.6K |
|
3097
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$4.43B
| $2.99M | ﹤0.01% |
55,321
-159
| -0.3% | -$8.15K |
|
3098
WisdomTree US Total Dividend Fund
DTD
$1.7B
| $2.99M | ﹤0.01% |
49,358
-330
| -0.7% | -$20.2K |
|
3099
Amylyx Pharmaceuticals
AMLX
$2.41B
| $2.98M | ﹤0.01% |
101,700
+51,999
| +105% | +$1.81M |
|
|
LUCK
3100
Lucky Strike Entertainment
LUCK
$949M
| $2.98M | ﹤0.01% |
175,626
+143,208
| +442% | +$2.12M |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.